What Is Type 2 Diabetes? Causes, Symptoms & Risks

Type 2 diabetes is a condition in which the body’s cells gradually lose their ability to respond to insulin, the hormone that moves sugar from the bloodstream into cells for energy. Over time, the pancreas can’t keep up with rising demand, blood sugar stays chronically elevated, and damage accumulates across multiple organ systems. It accounts for roughly 90–95% of all diabetes cases and develops through a mix of genetic susceptibility, lifestyle factors, and environmental exposures that researchers are still working to untangle.

How Type 2 Diabetes Develops

The process behind type 2 diabetes involves two interlocking problems: insulin resistance and declining insulin production. Insulin resistance means muscle, liver, and fat cells don’t respond efficiently to insulin’s signal. When muscle cells resist insulin, they absorb less glucose from the blood. When the liver resists insulin, it keeps producing glucose even when blood sugar is already high, pumping extra sugar into the bloodstream during fasting hours.¹ The mechanisms behind this resistance involve, among other things, fat building up in places it doesn’t belong (like inside liver and muscle tissue), chronic low-grade inflammation, and stress signals within cells.²

At first, the pancreas compensates. Its insulin-producing beta cells ramp up output to overcome resistance, and blood sugar stays near normal. But this overwork takes a toll. Inflammation and a buildup of damaging molecules called reactive oxygen species gradually wear down those beta cells.³ Eventually, beta cells become exhausted and their total mass shrinks, so the pancreas can no longer produce enough insulin to keep blood sugar in check.⁴ That’s when blood sugar climbs high enough to be diagnosed as diabetes. The period between normal blood sugar and diabetes is called prediabetes, and it can last years without producing obvious symptoms.

Why Body Fat Location Matters More Than Weight Alone

Being overweight raises the risk of type 2 diabetes, but the picture is more specific than just a number on the scale. Visceral fat, the fat that wraps around internal organs deep in the abdomen, appears to be the more important driver regardless of overall body mass.⁵ This fat is metabolically hyperactive: it releases free fatty acids into the bloodstream at a high rate, and those fatty acids directly promote insulin resistance in surrounding tissues. A study of a rural Indian population using CT scans found that people with diabetes had substantially more visceral fat than those without, and the difference was statistically significant.⁶

This helps explain why some people with a “normal” BMI still develop type 2 diabetes: they may carry a disproportionate amount of visceral fat relative to subcutaneous fat (the kind just under the skin). The ratio of visceral to subcutaneous fat appears to be a meaningful marker of metabolic risk on its own.⁷ It also helps explain why people of certain ethnic backgrounds, particularly South Asian and East Asian populations, develop type 2 diabetes at lower BMI thresholds than European-descended populations: differences in how body fat is distributed play a role.

The Genetic Landscape

Type 2 diabetes runs in families, and genetics clearly matter. If one of your parents has it, your lifetime risk goes up substantially. But the genetic architecture is complicated. Genome-wide studies have identified dozens of gene variants linked to type 2 diabetes risk, including well-established ones like TCF7L2, KCNQ1, and KCNJ11, but all of the known variants combined explain only a small fraction of the overall inherited risk.⁸ Most of the susceptibility genes discovered so far are involved in how beta cells develop and function, rather than in insulin resistance directly.⁹

Researchers used to think of type 2 diabetes in binary terms: either you had a rare, powerful single-gene mutation causing diabetes (monogenic) or you had the common form driven by lots of small-effect gene variants (polygenic). The current picture is messier. Emerging evidence points to a continuum that includes monogenic, oligogenic (a handful of moderately powerful variants), and polygenic contributions, all interacting with environment and lifestyle.¹⁰ In practical terms, this means that having a strong family history doesn’t make type 2 diabetes inevitable, and having no family history doesn’t make you immune.

Diet, Sleep, and Lifestyle Risks

Diet is one of the most studied modifiable risk factors. A large meta-analysis of prospective studies found that dietary patterns heavy in red and processed meat, refined grains, high-fat dairy, and fried foods were associated with roughly a 44% higher risk of developing type 2 diabetes compared to healthier eating patterns. Meanwhile, adherence to the Mediterranean diet, the DASH diet, or the Alternative Healthy Eating Index was linked to risk reductions ranging from about 13% to 21%.¹¹ Excessive consumption of ultra-processed foods is consistently tied to higher risk as well.¹²

Physical inactivity is another major factor. Sedentary behavior promotes visceral fat accumulation, weakens the muscles’ ability to absorb glucose, and compounds the metabolic effects of poor diet. Even moderate regular activity, like brisk walking, significantly lowers risk.

Sleep disruption deserves more attention than it usually gets. Shift work, particularly night shifts, has been identified as an independent risk factor. One cross-sectional study found that shift workers had roughly double the odds of type 2 diabetes compared to day workers, even after adjusting for BMI, smoking, alcohol, and sleep quality.¹³ Among people who already have type 2 diabetes, night-shift workers tend to have worse blood-sugar control than day workers.¹⁴

What makes the sleep connection especially interesting is the role of chronotype, your body’s natural preference for sleeping earlier or later. A study from the Nurses’ Health Study cohorts found that the risk from shift work depended on whether the schedule matched or clashed with a person’s internal clock. Late chronotypes (“night owls”) working day shifts actually had elevated diabetes risk, while the same group working night shifts did not. Early chronotypes working more than ten years of rotating night shifts saw their advantage erode.¹⁵ The takeaway is that it’s not just how much you sleep, but how well your sleep schedule aligns with your biology.

Symptoms and Why They’re Easy to Miss

Type 2 diabetes often develops silently. The classic symptoms, increased thirst, frequent urination, blurred vision, slow-healing wounds, and fatigue, typically don’t become noticeable until blood sugar has been elevated for a while. Many people spend years in the prediabetes range without knowing. About a quarter of people with prediabetes go on to develop type 2 diabetes within three to five years, and roughly 90% of prediabetic individuals are unaware of their condition.¹⁶

Other symptoms people sometimes overlook include tingling or numbness in the hands and feet, darkened patches of skin (particularly around the neck or armpits, a sign called acanthosis nigricans), recurrent yeast infections, and unexplained weight loss despite eating normally. Because none of these scream “diabetes” to most people, the condition is frequently caught only through routine blood tests. This is why screening guidelines recommend regular checks for anyone over 35, or earlier if additional risk factors are present.

Distinguishing Type 2 from Type 1

Occasionally, when an adult shows up with newly elevated blood sugar, it’s not immediately clear whether they have type 2 diabetes or a late-onset form of type 1, which is an autoimmune disease where the immune system destroys beta cells. The distinction matters because treatment differs significantly. When the type of diabetes is ambiguous, the most reliable diagnostic tool is testing for diabetes-specific autoantibodies. Their presence points toward type 1; their absence generally confirms type 2.¹⁷ A related condition called LADA (latent autoimmune diabetes in adults) can initially look like type 2 but progress more rapidly because it is autoimmune in nature. If you’re diagnosed with type 2 diabetes but find that standard treatments fail quickly, autoantibody testing is worth requesting.

Long-Term Complications

Chronically elevated blood sugar damages blood vessels throughout the body. The complications break down into two broad categories: damage to small blood vessels (microvascular) and damage to large ones (macrovascular).

The three major microvascular complications are retinopathy (eye damage that can lead to blindness), nephropathy (kidney damage that can progress to kidney failure), and neuropathy (nerve damage, usually starting in the feet). These complications share underlying mechanisms and often appear together, meaning a person who develops one is at heightened risk for the others.¹⁸

On the macrovascular side, type 2 diabetes sharply increases the risk of heart disease and stroke. One study of type 2 diabetes patients found that the ten-year risk of coronary heart disease was roughly 28% in those with carotid artery thickening compared to about 15% in those without it, and the stroke risk pattern was similar.¹⁹ Cardiovascular disease remains the leading cause of death in people with type 2 diabetes, which is why modern treatment increasingly focuses on reducing heart and kidney risk alongside controlling blood sugar.

The Fatty Liver Connection

Nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes overlap so commonly that some researchers consider them two faces of the same metabolic problem. NAFLD has been found in roughly 70% of people with type 2 diabetes.²⁰ The relationship runs in both directions: a fatty liver worsens insulin resistance and drives blood sugar higher, while type 2 diabetes itself promotes the progression of simple fatty liver into a more damaging form involving liver inflammation and scarring.²¹ This bidirectional dynamic means the two conditions fuel each other.²²

In practice, if you’re diagnosed with type 2 diabetes, it’s worth asking your doctor about liver health. A fatty liver is usually symptom-free and easily missed unless specifically checked. Treating one condition, through weight loss or medication, often improves the other.

Environmental Chemical Exposures

Beyond the familiar risk factors, a growing body of research links environmental chemicals to type 2 diabetes risk. Endocrine-disrupting chemicals (EDCs), substances that interfere with hormonal signaling, are found in pesticides, plastics, industrial solvents, and other everyday products. A systematic review and meta-analysis found that people with the highest blood levels of dioxins, PCBs, and chlorinated pesticides had roughly double the risk of type 2 diabetes compared to those with the lowest levels. Bisphenol A (BPA), a chemical common in plastic containers, was associated with about a 45% increase in risk.²³ These chemicals were also associated with indicators of impaired fasting glucose and insulin resistance.

Some EDCs appear to exert their effects by binding to hormone receptors, including androgen receptors, which disrupts metabolic pathways involved in glucose and fat metabolism.²⁴ The evidence is still being assembled, and proving causation from epidemiological data is tricky. But the associations are consistent enough that some public health researchers argue EDC exposure should be treated as a legitimate, if secondary, contributor to the type 2 diabetes epidemic.²⁵

Can Type 2 Diabetes Be Put into Remission?

One of the more encouraging developments in recent years is the evidence that type 2 diabetes can be reversed, or more precisely, put into remission, particularly if caught early. The key insight is that excess fat in the liver and pancreas appears to drive much of the disease. When people lose a substantial amount of weight, liver fat drops and the organ starts responding to insulin normally again. The pancreas, freed from fat-induced metabolic stress, can recover some of its insulin-producing function.²⁶

Research from the Counterpoint study showed that liver glucose handling returned to normal within about a week of significant calorie restriction, and beta-cell function improved substantially over two months. Even more remarkably, during the first year of remission, the maximum functional beta-cell mass returned completely to normal and remained so for at least two years.²⁷ The underlying mechanism involves reducing the liver’s export of fat particles, which in turn lowers fat accumulation in the pancreas and allows the return of normal insulin secretion.²⁸

There are important caveats. Remission is most achievable in people diagnosed within the first few years, when beta-cell damage is still potentially reversible. The longer someone has had diabetes, the harder remission becomes. Weight regain almost invariably brings the diabetes back. And “remission” is not “cure”: the underlying susceptibility persists, so maintaining the weight loss is essential.

The Gut Microbiome

Your intestinal bacteria play a larger role in blood sugar control than most people realize. Systematic reviews have consistently found that people with type 2 diabetes show disrupted gut bacterial communities, a state called dysbiosis, which is associated with reduced insulin sensitivity and poorer blood sugar control.²⁹ The proposed mechanism involves a “leaky gut,” where a less healthy bacterial population weakens the intestinal lining and allows inflammatory molecules to enter the bloodstream, promoting chronic low-grade inflammation that worsens insulin resistance.

This doesn’t mean probiotics are a cure for diabetes. The field is still sorting out which bacterial species matter, whether the changes in gut bacteria are a cause or a consequence of diabetes, and whether manipulating the microbiome has lasting effects on blood sugar. But it does add to the picture of type 2 diabetes as a whole-body condition with roots in multiple systems beyond just the pancreas.

Medications That Have Changed the Treatment Landscape

Metformin remains the first-line drug for most people with type 2 diabetes, primarily by reducing the liver’s glucose output. But two newer drug classes have reshaped how clinicians think about treatment. GLP-1 receptor agonists (the class that includes semaglutide, the active ingredient in Ozempic and Wegovy) mimic a gut hormone that stimulates insulin release, suppresses appetite, and slows stomach emptying. SGLT2 inhibitors work through a completely different route: they cause the kidneys to excrete excess glucose into the urine.³⁰

What makes these classes stand out is that both have demonstrated benefits beyond blood sugar control, including reductions in cardiovascular events and protection against kidney disease progression. They appear to achieve these benefits through different mechanisms: SGLT2 inhibitors primarily through effects on fluid balance and blood pressure, GLP-1 receptor agonists through anti-inflammatory and anti-plaque effects on blood vessels. Because their mechanisms are complementary, combining the two classes is increasingly common.³¹

Programming That Starts Before Birth

Some of the risk for type 2 diabetes is set in motion long before adulthood, even before birth. Conditions in the womb can “program” a developing baby’s metabolism in ways that increase vulnerability decades later. Maternal overnutrition, gestational diabetes, and excessive weight gain during pregnancy can lead to fetal overgrowth and raise the child’s risk of obesity and type 2 diabetes in both childhood and adulthood.³²

The opposite extreme is also risky. Babies who experience poor nutrition in the womb and are born small tend to undergo rapid “catch-up” growth after birth, and this pattern has been linked to unfavorable changes in fat distribution (particularly more visceral fat), impaired pancreatic beta-cell development, and reduced insulin-producing capacity that may persist for life.³³ Epigenetic changes, modifications to how genes are expressed without altering the DNA sequence itself, appear to be one of the mechanisms through which the uterine environment leaves a lasting metabolic imprint.³⁴

The “Thrifty Gene” Debate

In 1962, geneticist James Neel proposed what became known as the thrifty gene hypothesis: that genes promoting efficient fat storage and conservative energy use would have been advantageous throughout most of human evolution, when food was scarce, but became harmful once calories became abundant. The idea was attractive as an explanation for why type 2 diabetes is so common in modern societies.³⁵

The hypothesis has not aged well under genetic scrutiny. A study that analyzed 65 gene variants linked to type 2 diabetes susceptibility found no overall signal that natural selection had specifically favored the risk-increasing versions. Protective and risk alleles appeared to have been selected in similar proportions, and any selection detected was likely unrelated to diabetes itself.³⁶ The idea that our ancestors were under strong evolutionary pressure to accumulate diabetes-promoting genes is, at best, an incomplete explanation. What’s more firmly established is the mismatch concept in a broader sense: human metabolism evolved in a context of periodic scarcity and regular physical activity, and it struggles when confronted with unlimited calorie-dense food and a sedentary lifestyle. But that environmental mismatch doesn’t require a specific set of “thrifty genes” to explain the diabetes epidemic.